Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nitropcr
AddedFeb 18, 2024
UpdatedJun 18, 2026
Nitropcr

Nitropcr

Seed

NitroPCR: A cost-effective, SaaS-based mobile PCR system for EMS crews, offering swift setup and training.

HQ
Mobile, AL, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

NitroPCR is dedicated to revolutionizing the way Emergency Medical Services (EMS) handle patient care reporting. Their core mission is to provide a cost-effective, efficient, and user-friendly SaaS-based mobile PCR system that allows EMS crews to produce HIPAA and NEMSIS compliant Patient Care Reports on mobile devices. The service operates on a pay-as-you-go subscription model, significantly reducing start-up costs and implementation time compared to traditional ePCR systems. NitroPCR ensures users can be fully operational within a week, with training taking just 10 minutes through short instructional videos.

NitroPCR has made significant strides in the EMS market by integrating advanced technology like Google Glass, which sends crucial event information directly to the user's device. This innovation enhances the efficiency and accuracy of patient care reporting in emergency situations. The company's streamlined approach and rapid deployment have positioned it as a valuable tool for EMS providers, contributing to improved patient care and operational efficiency.

Nitropcr - Similar Companies

Neighborhood Nurse logo

Neighborhood Nurse

DexCare logo

DexCare

Patient Premier logo

Patient Premier

patientpremier.com

Pemrs logo

Pemrs

emr4me.com

Narrable logo

Narrable

narrablehealth.com

EmOpti logo

EmOpti

emopti.com

Kinetik logo

Kinetik

kinetik.care

Nephosity logo

Nephosity

nephosity.com

Famwork logo

Famwork

Keriton logo

Keriton

keriton.com

Anima logo

Anima

animahealth.com

Health Compiler logo

Health Compiler

Repisodic logo

Repisodic

repisodic.com

Format Health logo

Format Health

formathealth.com

Nitropcr - Quick Facts

Who are Nitropcr's competitors?

Companies similar to Nitropcr include Neighborhood Nurse, DexCare, Patient Premier and Pemrs.

When was Nitropcr founded?

Nitropcr was founded in 2013.

Where is Nitropcr's headquarters located?

Nitropcr's headquarters is located in Mobile, AL, US.

When was Nitropcr's last funding round?

Nitropcr's most recent funding round was for $75k (USD) in August 2015.

How much has Nitropcr raised to-date?

As of Aug 27, 2015, Nitropcr has raised a total of $205k (USD).

How many employees does Nitropcr have?

Nitropcr has 5 employees as of Feb 4, 2024.

Nitropcr - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Patient Care Reports
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software